...年来首个MS治疗药物 凯龙公司(Chiron)的重组干扰素β-1b(Betaseron)获准上市,用于治疗多发性硬化症(multiple sclerosis,MS),这是20年来首个获准治疗MS的新药。
基于8个网页-相关网页
法国制药公司赛诺菲-安万特同时也在就自己的治疗多发性硬化症的口服药物teriflunomide的大型临床试验。
France's Sanofi-Aventis SA, meanwhile, is carrying out large clinical trials of an oral MS drug called teriflunomide.
治疗多发性硬化症是复杂的,可能需要参考神经医生的建议。目前无法治愈,但是治疗包括药物,理疗可能起作用。
Diagnosing MS is complicated and may require referral to a neurologist. There is currently no cure but treatments including medication and physiotherapy may help.
澳大利亚研究员已发现人类肌肉行为全新的一面,这对于治疗中风和多发性硬化症有一定的意义。
Australian researchers have discovered an entirely new aspect of human muscle behaviour which has implications for treating stroke and multiple sclerosis.
应用推荐